| Title |
Poor Concordance Between Cancer Antigen-125 and RECIST Assessment for Progression in Patients With Platinum-Sensitive Relapsed Ovarian Cancer on Maintenance Therapy With a Poly(ADP-ribose) Polymerase Inhibitor.
|
|---|---|
| Published in |
Journal of Clinical Oncology, January 2024
|
| DOI | 10.1200/jco.23.01182 |
| Pubmed ID | |
| Authors |
Angelina Tjokrowidjaja, M.L. Friedlander, Jonathan A. Ledermann, Robert L. Coleman, Mansoor R. Mirza, Ursula A. Matulonis, Eric Pujade-Lauraine, Sarah J. Lord, Clare L. Scott, Sandra Goble, Whitney York, Chee K. Lee, Chee Khoon Lee, Benoit You, Xavier Paoletti, Ros Glasspool, Michael Friedlander, Clare Scott, Monsoor Mirza, Eric Pujade Lauraine, Jonathan Ledermann, Yoland Antill, Linda Mileshkin, Josee-Lyne Ethier, Michael Bookman, Charlie Gourley |
X Demographics
The data shown below were collected from the profiles of 22 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 5 | 23% |
| Australia | 4 | 18% |
| Spain | 1 | 5% |
| Japan | 1 | 5% |
| Egypt | 1 | 5% |
| New Zealand | 1 | 5% |
| India | 1 | 5% |
| Switzerland | 1 | 5% |
| Singapore | 1 | 5% |
| Other | 0 | 0% |
| Unknown | 6 | 27% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 10 | 45% |
| Members of the public | 10 | 45% |
| Scientists | 2 | 9% |
Mendeley readers
The data shown below were compiled from readership statistics for 3 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 3 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 1 | 33% |
| Professor | 1 | 33% |
| Student > Ph. D. Student | 1 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 3 | 100% |
Attention Score in Context
This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 April 2024.
All research outputs
#1,397,520
of 25,715,849 outputs
Outputs from Journal of Clinical Oncology
#3,434
of 22,215 outputs
Outputs of similar age
#21,241
of 351,358 outputs
Outputs of similar age from Journal of Clinical Oncology
#55
of 195 outputs
Altmetric has tracked 25,715,849 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,215 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.1. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,358 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 195 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.